UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
A Combinatorial CRISPR–Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment Journal article
Xu, Feng, Tong, Man, Tong, Cindy S.W., Chan, Becky K.C., Chu, Hoi Yee, Wong, Tin Lok, Fong, John H.C., Cheung, Maggie S.H., Mak, Kylie Hin Man, Pardeshi, Lakhansing, Huang, Yuanhua, Wong, Koon Ho, Choi, Gigi C.G., Ma, Stephanie, Wong, Alan S.L.. A Combinatorial CRISPR–Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment[J]. Cancer Research, 2021, 81(24), 6219-6232.
Authors:  Xu, Feng;  Tong, Man;  Tong, Cindy S.W.;  Chan, Becky K.C.;  Chu, Hoi Yee; et al.
Favorite | TC[WOS]:15 TC[Scopus]:18  IF:12.5/11.6 | Submit date:2022/05/11